CareDx, Inc. Files 8-K on Financials
Ticker: CDNA · Form: 8-K · Filed: Oct 15, 2024 · CIK: 1217234
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: CDNA
TL;DR
CareDx dropped an 8-K on Oct 15th - check their financials!
AI Summary
On October 15, 2024, CareDx, Inc. filed an 8-K report detailing results of operations and financial condition, along with Regulation FD disclosures and financial statements. The filing pertains to the company's ongoing business operations and financial reporting.
Why It Matters
This filing provides an update on CareDx's financial performance and operational results, which is crucial for investors to assess the company's current health and future prospects.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for financial reporting and does not appear to contain any unexpected or negative news.
Key Players & Entities
- CareDx, Inc. (company) — Registrant
- October 15, 2024 (date) — Date of Report
- 8000 Marina Boulevard, 4th Floor, Brisbane, California 94005 (address) — Principal Executive Offices
- 001-36536 (company_id) — Commission File Number
- 94-3316839 (tax_id) — IRS Employer Identification No.
FAQ
What specific financial information is being disclosed in this 8-K filing?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', suggesting a disclosure of financial performance and related documents.
What is the primary purpose of this 8-K filing for CareDx, Inc.?
The primary purpose is to report on the company's results of operations and financial condition, as well as to provide Regulation FD disclosures and financial statements.
When was this 8-K report filed?
The report was filed on October 15, 2024.
What is CareDx, Inc.'s principal executive office address?
The principal executive offices are located at 8000 Marina Boulevard, 4th Floor, Brisbane, California 94005.
Does this filing indicate any significant changes or events for CareDx, Inc. beyond routine financial reporting?
Based on the provided text, the filing is categorized under 'Results of Operations and Financial Condition', 'Regulation FD Disclosure', and 'Financial Statements and Exhibits', suggesting it is primarily for financial reporting and not for a specific material event outside of normal operations.
Filing Stats: 678 words · 3 min read · ~2 pages · Grade level 10.1 · Accepted 2024-10-15 07:56:35
Key Financial Figures
- $0.001 — ge on which registered) Common Stock, $0.001 Par Value CDNA The Nasdaq Stock Mar
Filing Documents
- d889373d8k.htm (8-K) — 27KB
- d889373dex991.htm (EX-99.1) — 11KB
- d889373dex992.htm (EX-99.2) — 45KB
- g889373ex99_2p10g1.jpg (GRAPHIC) — 167KB
- g889373ex99_2p11g1.jpg (GRAPHIC) — 164KB
- g889373ex99_2p12g1.jpg (GRAPHIC) — 170KB
- g889373ex99_2p13g1.jpg (GRAPHIC) — 159KB
- g889373ex99_2p14g1.jpg (GRAPHIC) — 111KB
- g889373ex99_2p15g1.jpg (GRAPHIC) — 141KB
- g889373ex99_2p16g1.jpg (GRAPHIC) — 158KB
- g889373ex99_2p17g1.jpg (GRAPHIC) — 147KB
- g889373ex99_2p18g1.jpg (GRAPHIC) — 245KB
- g889373ex99_2p19g1.jpg (GRAPHIC) — 216KB
- g889373ex99_2p1g1.jpg (GRAPHIC) — 115KB
- g889373ex99_2p20g1.jpg (GRAPHIC) — 158KB
- g889373ex99_2p21g1.jpg (GRAPHIC) — 243KB
- g889373ex99_2p22g1.jpg (GRAPHIC) — 181KB
- g889373ex99_2p23g1.jpg (GRAPHIC) — 164KB
- g889373ex99_2p24g1.jpg (GRAPHIC) — 181KB
- g889373ex99_2p25g1.jpg (GRAPHIC) — 147KB
- g889373ex99_2p26g1.jpg (GRAPHIC) — 123KB
- g889373ex99_2p27g1.jpg (GRAPHIC) — 188KB
- g889373ex99_2p28g1.jpg (GRAPHIC) — 237KB
- g889373ex99_2p29g1.jpg (GRAPHIC) — 273KB
- g889373ex99_2p2g1.jpg (GRAPHIC) — 498KB
- g889373ex99_2p30g1.jpg (GRAPHIC) — 330KB
- g889373ex99_2p31g1.jpg (GRAPHIC) — 210KB
- g889373ex99_2p32g1.jpg (GRAPHIC) — 104KB
- g889373ex99_2p33g1.jpg (GRAPHIC) — 177KB
- g889373ex99_2p34g1.jpg (GRAPHIC) — 201KB
- g889373ex99_2p35g1.jpg (GRAPHIC) — 204KB
- g889373ex99_2p36g1.jpg (GRAPHIC) — 203KB
- g889373ex99_2p37g1.jpg (GRAPHIC) — 208KB
- g889373ex99_2p38g1.jpg (GRAPHIC) — 283KB
- g889373ex99_2p39g1.jpg (GRAPHIC) — 154KB
- g889373ex99_2p3g1.jpg (GRAPHIC) — 131KB
- g889373ex99_2p40g1.jpg (GRAPHIC) — 127KB
- g889373ex99_2p41g1.jpg (GRAPHIC) — 113KB
- g889373ex99_2p42g1.jpg (GRAPHIC) — 178KB
- g889373ex99_2p43g1.jpg (GRAPHIC) — 112KB
- g889373ex99_2p44g1.jpg (GRAPHIC) — 115KB
- g889373ex99_2p45g1.jpg (GRAPHIC) — 108KB
- g889373ex99_2p46g1.jpg (GRAPHIC) — 118KB
- g889373ex99_2p47g1.jpg (GRAPHIC) — 137KB
- g889373ex99_2p48g1.jpg (GRAPHIC) — 145KB
- g889373ex99_2p49g1.jpg (GRAPHIC) — 144KB
- g889373ex99_2p4g1.jpg (GRAPHIC) — 235KB
- g889373ex99_2p50g1.jpg (GRAPHIC) — 207KB
- g889373ex99_2p51g1.jpg (GRAPHIC) — 243KB
- g889373ex99_2p52g1.jpg (GRAPHIC) — 232KB
- g889373ex99_2p53g1.jpg (GRAPHIC) — 139KB
- g889373ex99_2p54g1.jpg (GRAPHIC) — 137KB
- g889373ex99_2p55g1.jpg (GRAPHIC) — 103KB
- g889373ex99_2p56g1.jpg (GRAPHIC) — 159KB
- g889373ex99_2p57g1.jpg (GRAPHIC) — 125KB
- g889373ex99_2p58g1.jpg (GRAPHIC) — 116KB
- g889373ex99_2p59g1.jpg (GRAPHIC) — 133KB
- g889373ex99_2p5g1.jpg (GRAPHIC) — 103KB
- g889373ex99_2p60g1.jpg (GRAPHIC) — 233KB
- g889373ex99_2p6g1.jpg (GRAPHIC) — 288KB
- g889373ex99_2p7g1.jpg (GRAPHIC) — 182KB
- g889373ex99_2p8g1.jpg (GRAPHIC) — 186KB
- g889373ex99_2p9g1.jpg (GRAPHIC) — 219KB
- 0001193125-24-237218.txt ( ) — 15004KB
- cdna-20241015.xsd (EX-101.SCH) — 3KB
- cdna-20241015_lab.xml (EX-101.LAB) — 18KB
- cdna-20241015_pre.xml (EX-101.PRE) — 11KB
- d889373d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release issued by CareDx, Inc., dated October 15, 2024. 99.2 Corporate Presentation of CareDx, Inc., dated October 15, 2024. 104 Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL). - 2 -
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 15, 2024 CAREDX, INC. By: /s/ John W. Hanna John W. Hanna President and Chief Executive Officer - 3 -